Form D · Biotechnology
Palleon Pharmaceuticals Inc.
Waltham, MA · CIK 0001678852
Offering snapshot reported Sep 17, 2020 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 2, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 17, 2020 | Initial | $100,000,007 | No comparison | 7 | SEC filing |
| Nov 17, 2017 | Amendment | $20,612,790 | $12,012,790vs Jul 7, 2016 | 6 | SEC filing |
| Jul 7, 2016 | Initial | $8,600,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-375741
Source: Form D, filed Sep 17, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James W. Broderick | Director, Executive |
| William Burkoth | Director |
| Rajeev Dadoo | Director |
| Jens Eckstein | Director |
| John Hennessy | Executive |
| Stephen Hoffman | Director |
| Karen Hong | Director |
| James Lee | Director |
| Karan Takhar | Director |
| Eric Xiao | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
266 Second Avenue, 2 Nd Floor
Waltham, MA, 02451
Waltham, MA, 02451